Results 11 to 20 of about 282,210 (204)

The performance of licensed rotavirus vaccines and the development of a new generation of rotavirus vaccines: a review [PDF]

open access: yesHuman Vaccines & Immunotherapeutics, 2021
Rotavirus, which causes acute gastroenteritis and severe diarrhea, has posed a great threat to children worldwide over the last 30 y. Since no specific drugs and therapies against rotavirus are available, vaccination is considered the most effective ...
Yuxiao Wang   +3 more
doaj   +3 more sources

The Challenges and Opportunities of Next-Generation Rotavirus Vaccines: Summary of an Expert Meeting with Vaccine Developers [PDF]

open access: yesViruses, 2022
The 2nd Next Generation Rotavirus Vaccine Developers Meeting, sponsored by PATH and the Bill and Melinda Gates Foundation, was held in London, UK (7–8 June 2022), and attended by vaccine developers and researchers to discuss advancements in the ...
Jessie Chen   +5 more
doaj   +3 more sources

Rotavirus Vaccines

open access: yesIndian Journal of Medical Microbiology, 2006
Rotavirus, the most common cause of severe diarrhea and a leading cause of mortality in children, has been a priority target for vaccine development for the past several years. The first rotavirus vaccine licensed in the United States was withdrawn because of an association of the vaccine with intussusception.
Kang, G., G Kang
europepmc   +4 more sources

Leveraging Beneficial Off-Target Effects of Live-Attenuated Rotavirus Vaccines [PDF]

open access: yesVaccines, 2022
Following the introduction of live-attenuated rotavirus vaccines in many countries, a notable reduction in deaths and hospitalisations associated with diarrhoea in children
Prisca Benedicto-Matambo   +11 more
doaj   +4 more sources

Estimating the global impact of rotavirus vaccines on child mortality [PDF]

open access: yesInternational Journal of Infectious Diseases, 2023
Objectives: We estimated the global impact of rotavirus vaccines on deaths among children under five years old by year. Methods: We used a proportionate outcomes model with a finely disaggregated age structure to estimate rotavirus deaths prevented by ...
Andrew Clark   +10 more
doaj   +2 more sources

Rotaviruses and Rotavirus Vaccines [PDF]

open access: yesPathogens, 2021
Group A rotaviruses belong to the Reoviridae virus family and are classified into G and P genotypes based on the outer capsid proteins VP7 and VP4, respectively [...]
Celeste M. Donato, Julie E. Bines
openaire   +5 more sources

Recommendations for Rotavirus Vaccine

open access: yesPediatrics and Neonatology, 2013
Rotavirus infection has been the leading cause of gastroenteritis among children in Taiwan. Studies have shown that 40% of hospitalization for acute gastroenteritis can be prevented through the use of vaccines, including a live, attenuated monovalent ...
Ping-Ing Lee   +16 more
doaj   +3 more sources

Immune response to rotavirus vaccines in low- and middle-income countries: Challenges and perspectives [PDF]

open access: yesHuman Vaccines & Immunotherapeutics
Rotavirus is a highly contagious pathogen and a leading cause of severe diarrhea cases in children under 5 y of age worldwide. Although effective oral rotavirus vaccines have been developed and implemented globally, their performance varies substantially
Elena Morandi   +5 more
doaj   +2 more sources

Update on Early-Life T Cells: Impact on Oral Rotavirus Vaccines [PDF]

open access: yesViruses
Rotavirus infection continues to be a significant public health problem in developing countries, despite the availability of several vaccines. The efficacy of oral rotavirus vaccines in young children may be affected by significant immunological ...
Catherine Montenegro   +2 more
doaj   +2 more sources

Rotavirus infection and the current status of rotavirus vaccines

open access: yesJournal of the Formosan Medical Association, 2012
Among children, rotaviruses are the most common cause of severe gastroenteritis worldwide and of diarrheal deaths in developing countries. Current vaccines (e.g., Rotarix, GlaxoSmithKline Biologicals; RotaTeq, Merck and Company) effectively reduce ...
Shou-Chien Chen   +3 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy